CHU, Hôpital A. Michalon, Laboratoire de Pharmacologie-Toxicologie, BP217, Grenoble 38043, France.
Anal Chim Acta. 2013 Dec 17;805:80-6. doi: 10.1016/j.aca.2013.10.051. Epub 2013 Nov 6.
In the last decade the quantitation of immunosuppressive drugs has seen vast improvements in analytical methods, optimizing time, accuracy of analysis and cost. Laser Diode Thermal Desorption (LDTD) coupled to Atmospheric Pressure Chemical ionization-tandem mass spectrometry (APCI-MS/MS) represents a technological breakthrough that removes the chromatographic separation step and thereby significantly increases the analytical throughput for the quantitation of cyclosporin A (CsA) in whole blood for therapeutic drug monitoring (TDM). A simple protein precipitation step was used prior to depositing 5 μL of the extract on a 96-well LazWell™ plate and CsA was quantified by LDTD-APCI-MS/MS. The laser pattern was set to ramp from 0 to 45% laser power within 2 s. The APCI parameters were set to negative needle voltage (-2 μA), carrier gas temperature (30°C) and air flow rate (3 L min(-1)). The negative ion single reaction monitoring transitions for CsA and its internal standard cyclosporin D (CsD) were respectively m/z 1201.1/1088.9 and m/z 1214.8/1102.8; obtained with a collision energy of -40 V. The analysis was achieved within 9 s from sample to sample. The extraction procedure yielded high recovery (92%; RSD=9.4%, n=6). The lower limit of quantitation was fixed at the first level of calibration: 23.5 ng mL(-1) (accuracy=112.3%; RSD=9.6%; n=6) and a blank+6 point linear regression up to 965 ng mL(-1) was used. Using 4 levels of quality control (QC), intra-day assays (n=6) ranged from 93.5 to 95.7% (bias) and from 3.4 to 13.1% (RSD) while inter-day assays (n=6) ranged from 92.9 to 105.3% (bias) and from 4.9 to 7.5% (RSD). An inter-sample contamination of CsA of 2.3% was calculated that was considered negligible with respect to the range of CsA concentrations. Whole blood samples (120) from patients under CsA treatment were analyzed by LDTD-APCI-MS/MS and HPLC-ESI-MS/MS, the gold standard reference method for CsA quantification. Both methods agreed (P≥0.99), with a coefficient of correlation of 0.99 (95% confidence interval 0.982-0.991). The Passing-Bablok regression revealed no significant deviation from linearity (Cusum test, P=0.11). This method seems suitable for use in TDM of CsA.
在过去十年中,免疫抑制药物的定量分析在分析方法上取得了巨大的进步,优化了时间、分析准确性和成本。激光二极管热解吸(LDTD)与大气压化学电离-串联质谱(APCI-MS/MS)相结合代表了一项技术突破,它省去了色谱分离步骤,从而显著提高了环孢素 A(CsA)在全血中治疗药物监测(TDM)的定量分析通量。在将 5μL 提取物沉积在 96 孔 LazWell™板上之前,使用简单的蛋白质沉淀步骤,并用 LDTD-APCI-MS/MS 定量 CsA。激光模式设置为在 2 秒内从 0 到 45%的激光功率线性增加。APCI 参数设置为负针电压(-2μA)、载气温度(30°C)和空气流速(3L min(-1))。CsA 和其内标环孢素 D(CsD)的负离子单反应监测跃迁分别为 m/z 1201.1/1088.9 和 m/z 1214.8/1102.8;使用-40V 的碰撞能获得。分析从样品到样品的时间在 9 秒内完成。提取程序得到了高回收率(92%;RSD=9.4%,n=6)。定量下限固定在第一个校准水平:23.5ng mL(-1)(准确度=112.3%;RSD=9.6%;n=6),并使用空白+6 点线性回归至 965ng mL(-1)。使用 4 个质控(QC)水平,日内测定(n=6)的偏差范围为 93.5%至 95.7%(偏差)和 3.4%至 13.1%(RSD),而日间测定(n=6)的偏差范围为 92.9%至 105.3%(偏差)和 4.9%至 7.5%(RSD)。计算出 CsA 的样本间污染为 2.3%,考虑到 CsA 浓度范围,这被认为是可以忽略不计的。通过 LDTD-APCI-MS/MS 和 HPLC-ESI-MS/MS 分析 CsA 治疗患者的 120 个全血样本,HPLC-ESI-MS/MS 是 CsA 定量的金标准参考方法。两种方法均一致(P≥0.99),相关系数为 0.99(95%置信区间为 0.982-0.991)。通过 Passing-Bablok 回归显示没有明显的线性偏差(Cusum 检验,P=0.11)。该方法似乎适用于 CsA 的 TDM。